SPARC and cancer: It has also been shown that osteonectin, a collagen binding bone matrix protein, is upregulated in prostate cancer bone metastases and stimulates the invasion and migration of prostate cancer cells [149], however other studies have shown that osteonectin-null mice had accelerated cancer progression, invasion and metastases [150,151].